Neurodynamics to Improve Jump Functionality in Trampoline Jump Gymnasts

Investigación en Hemofilia y Fisioterapia

Status: Withdrawn

Conditions: Athlete Foot

Treatments: Other: Neurodynamic training

Study type: Interventional

Funder types: NETWORK

Identifiers

NCT04289857

Neuro

Details and patient eligibility

About

The goal of neurodynamics is to restore homeostasis of peripheral nerves. In the current context there is varied evidence that links neurodynamics with clinical pain treatments or different pathologies, but little evidence regarding changes in the functionality of athletes, which could be related to improvements in performance.

The main objective of the study is to determine if the neurodynamic technique is effective in increasing the range of hip mobility and in increasing the jump with counter movement.

Randomized, simple blind clinical study. 15 trampoline jumping gymnasts will be randomized to the two study groups: experimental (active sciatic neurodynamics techniques) and control (without intervention). The intervention will last 4 weeks, with 3 weekly sessions of approximately 5 minutes each. The study variables will be the range of hip flexion movement (goniometry) and the countermove jump (My Jump® application). A descriptive statistical analysis will be performed calculating the main statistical characteristics. The sample distribution will be calculated using a Shapiro-Wills analysis. The changes after each evaluation will be analyzed with the t-student test and with an ANOVA of repeated measures the intra and intersubject effect will be observed. The effect size will be calculated using Cohen's formula.

It is intended to observe improvement in the range of hip flexion movement and in the jump with countermovement.

Sex: Male

Ages: 18 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Trampoline jumping gymnasts
• Male
• Aged between 18 and 30 years
• Who train at least 2 days a week
• Federated in the Madrid Gymnastics Federation

Exclusion criteria

• Subjects who have a medical diagnosis of musculoskeletal pathology at the time of beginning the study
• Neural pathology in the last 6 months
• With cognitive deficit that prevents them from understanding physical tests and questionnaires
• Have not signed the informed consent

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 2 patient groups

Experimental group

Experimental group

Description:

Each session will last a maximum of 5 minutes, taking place for 3 days a week, over a period of 4 weeks. The intervention will be performed at the start of training (before warm-up).

Treatment:

Other: Neurodynamic training

Control group

No Intervention group

Description:

Athletes included in the control group will not perform any intervention, continuing with their usual routine.